Journal of Neuroinflammation

Table 2 Correlation between dimethylarginines and inflammatory markers

From: Association of dimethylarginines and mediators of inflammation after acute ischemic stroke

	6 h		12 h		24 h		3 d		7 d
	R	P	R	P	R	P	R	P	R	P
ADMA vs. IL-6	0.059	0.659	−0.024	0.860	0.001	0.997	0.272	0.039	0.344	0.008
ADMA vs. CRP	−0.192	0.149	0.113	0.397	0.031	0.819	0.291	0.027	0.338	0.010
ADMA vs. S100B	−0.106	0.430	−0.073	0.585	0.144	0.279	0.082	0.540	0.214	0.106
ADMA vs. MMP-9	−0.104	0.440	−0.153	0.254	0.131	0.330	0.031	0.818	0.039	0.775
ADMA vs. TIMP-1	0.346	0.010	0.083	0.545	0.401	0.002	0.431	0.001	0.352	0.008
ADMA vs. MCP-1	0.179	0.179	−0.026	0.844	0.012	0.930	0.213	0.108	0.209	0.116
SDMA vs. IL-6	0.237	0.073	0.219	0.099	0.139	0.297	0.389	0.003	0.405	0.002
SDMA vs. CRP	−0.144	0.281	0.017	0.899	−0.023	0.863	0.207	0.119	0.197	0.138
SDMA vs. S100B	−0.110	0.410	0.033	0.808	0.135	0.313	0.036	0.788	0.182	0.170
SDMA vs. MMP-9	−0.062	0.649	−0.115	0.393	−0.132	0.329	−0.015	0.913	0.055	0.684
SDMA vs. TIMP-1	0.237	0.082	−0.015	0.914	0.048	0.726	0.170	0.215	0.271	0.046
SDMA vs. MCP-1	0.379	0.003	0.149	0.264	0.110	0.411	0.286	0.030	0.345	0.008

P <0.05 is considered statistically significant. ADMA, asymmetric dimethylarginine; CRP, C-reactive protein; IL-6, interleukin-6; MCP-1, monocyte chemotactic protein-1; MMP-9, matrix metalloproteinase-9; SDMA, symmetric dimethylarginine; TIMP-1, tissue inhibitor of matrix metalloproteinase-1.

Back to article page

ISSN: 1742-2094

Contact us

Submission enquiries: journalsubmissions@springernature.com